Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-13.10 Insider Own37.89% Shs Outstand5.09M Perf Week-1.87%
Market Cap5.34M Forward P/E- EPS next Y-0.56 Insider Trans0.00% Shs Float3.16M Perf Month-37.87%
Income-23.09M PEG- EPS next Q-1.05 Inst Own25.69% Short Float0.75% Perf Quarter17.63%
Sales33.25M P/S0.16 EPS this Y74.19% Inst Trans- Short Ratio0.19 Perf Half Y-67.44%
Book/sh-1.06 P/B- EPS next Y83.18% ROA-69.40% Short Interest0.02M Perf Year-89.18%
Cash/sh0.75 P/C1.39 EPS next 5Y- ROE-407.41% 52W Range0.61 - 13.42 Perf YTD-62.09%
Dividend Est.- P/FCF- EPS past 5Y7.90% ROI- 52W High-92.18% Beta0.48
Dividend TTM- Quick Ratio0.94 Sales past 5Y9.41% Gross Margin46.65% 52W Low72.13% ATR (14)0.19
Dividend Ex-Date- Current Ratio1.44 EPS Y/Y TTM-20.76% Oper. Margin-66.90% RSI (14)36.28 Volatility9.19% 14.63%
Employees85 Debt/Eq- Sales Y/Y TTM20.23% Profit Margin-69.44% Recom1.00 Target Price16.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q48.58% Payout- Rel Volume0.20 Prev Close1.06
Sales Surprise-27.12% EPS Surprise-146.15% Sales Q/Q-9.40% EarningsMay 15 AMC Avg Volume128.48K Price1.05
SMA20-26.51% SMA50-32.32% SMA200-72.21% Trades Volume26,310 Change-0.94%
May-15-24 09:53PM
May-06-24 10:30AM
May-03-24 08:50AM
Mar-26-24 04:30PM
09:22AM Loading…
Mar-19-24 09:22AM
Mar-15-24 09:52PM
Mar-08-24 09:00AM
Feb-23-24 08:40AM
Feb-20-24 08:10AM
Feb-05-24 05:15PM
Feb-02-24 08:07AM
04:15PM Loading…
Jan-11-24 04:15PM
Nov-22-23 09:55AM
Nov-11-23 12:05PM
Nov-09-23 05:10PM
Nov-03-23 08:30AM
Oct-31-23 08:01AM
Oct-10-23 09:00AM
Oct-05-23 09:00AM
Oct-04-23 08:30AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
Aug-11-23 08:25AM
Aug-10-23 08:30AM
08:30AM Loading…
Aug-04-23 08:30AM
Jul-13-23 09:00AM
Jul-12-23 08:00AM
Jul-03-23 11:42AM
Jun-12-23 09:00AM
Jun-01-23 09:15AM
May-30-23 09:00AM
May-15-23 09:50AM
May-12-23 09:55AM
May-11-23 09:00AM
May-09-23 09:00AM
Apr-28-23 10:00AM
Apr-26-23 10:00AM
Mar-27-23 08:00AM
Mar-17-23 01:30PM
Mar-11-23 07:50AM
Mar-10-23 02:25AM
Mar-09-23 08:20AM
Mar-08-23 04:03PM
Mar-02-23 09:00AM
Feb-22-23 08:00AM
Feb-15-23 08:00AM
Jan-24-23 10:27AM
Jan-09-23 01:00PM
Dec-16-22 08:30AM
Dec-06-22 10:18AM
Nov-30-22 02:08PM
Nov-28-22 11:05AM
Nov-21-22 08:48AM
Nov-16-22 06:39AM
Nov-14-22 10:05AM
Nov-10-22 11:52AM
Nov-08-22 04:45PM
Oct-31-22 08:55AM
Oct-24-22 07:45AM
Oct-20-22 11:40AM
Oct-18-22 10:30AM
Oct-14-22 08:40AM
Oct-12-22 02:00PM
Oct-05-22 05:00PM
Sep-29-22 10:04AM
Sep-27-22 06:21AM
Sep-26-22 08:30AM
Sep-13-22 08:30AM
Sep-06-22 10:31AM
Aug-18-22 11:05AM
Aug-17-22 08:02AM
Aug-12-22 08:33AM
Aug-04-22 08:30AM
Aug-01-22 11:00AM
Jul-27-22 08:45AM
Jul-12-22 08:00AM
Jun-09-22 09:44AM
May-31-22 10:42AM
May-24-22 11:29AM
May-19-22 09:48AM
May-16-22 08:00AM
May-13-22 07:00AM
May-06-22 08:25AM
May-05-22 08:30AM
Apr-21-22 01:20PM
Apr-13-22 10:10AM
Apr-08-22 07:58AM
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.